Syneos Health, Inc. (SYNH) — Financial statements
Income statement, balance sheet, and cash flow for Syneos Health, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 5,393↑3.5% | 5,213↑18.1% | 4,416↓5.6% | 4,676↑6.5% | 4,390 | |
| Cost of Revenue | 4,139↑3.6% | 3,994↑17.5% | 3,398↓6.8% | 3,646↑6.2% | 3,434 | |
| Gross Profit | 1,254↑2.9% | 1,218↑19.7% | 1,018↓1.2% | 1,030↑7.8% | 956 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 406 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 547↓4.1% | 571↑29.0% | 442↓0.9% | 446↑9.8% | 406 | |
| Other Expenses | 247↑4.9% | 236↑6.0% | 222↓8.3% | 242↑758.5% | 28 | |
| Operating Expenses | 794↓1.5% | 806↑21.3% | 665↓3.5% | 689↑1.3% | 680 | |
| Total Costs & Expenses | 4,933↑2.8% | 4,801↑18.2% | 4,063↓6.3% | 4,335↑5.4% | 4,114 | |
| Operating Results | ||||||
| Operating Income | 403↑3.6% | 389↑32.8% | 293↓9.7% | 325↑102.6% | 160 | |
| Depreciation & Amortization | 297↑11.1% | 267↓6.3% | 285↑17.5% | 242↓11.4% | 274 | |
| EBITDA | 700↑6.6% | 656↑13.5% | 578↑2.0% | 567↓2.5% | 581 | |
| EBIT | 395↑0.3% | 394↑33.9% | 295↑27.2% | 232↑23.2% | 188 | |
| Interest & Other Income | ||||||
| Net Interest Income | -79↓0.2% | -79↑12.8% | -91↑25.9% | -122↑3.7% | -127 | |
| Interest Income | 2↑1349.5% | 0.11↓58.1% | 0.27↓96.5% | 8↑104.6% | 4 | |
| Interest Expense | 81↑2.1% | 79↓12.9% | 91↓30.0% | 130↓0.7% | 131 | |
| Non-Operating Income | 8↑256.1% | -5↓259.9% | -1↓122.4% | 6↑122.4% | -28 | |
| Other Income / Expenses | -89↓19.6% | -74↑17.2% | -89↑34.2% | -136↓32.2% | -103 | |
| Income Before Tax | 315↓0.2% | 315↑54.7% | 204↑100.2% | 102↑77.6% | 57 | |
| Income Tax Expense | 48↓40.2% | 80↑638.9% | 11↑136.8% | -30↓189.6% | 33 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 266↑13.5% | 235↑21.8% | 193↑46.9% | 131↑440.5% | 24 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 266↑13.5% | 235↑21.8% | 193↑46.9% | 131↑440.5% | 24 | |
| Bottom-Line Net Income | 266↑13.5% | 235↑21.8% | 193↑46.9% | 131↑440.5% | 24 | |
| EPS (Basic) | 2.57↑13.7% | 2.26↑22.2% | 1.85↑45.7% | 1.27↑452.2% | 0.23 | |
| EPS (Diluted) | 2.54↑13.4% | 2.24↑22.4% | 1.83↑46.4% | 1.25↑443.5% | 0.23 | |
| Weighted Average Shares | 103↓0.9% | 104↓0.3% | 104↑0.5% | 104↑0.2% | 103 | |
| Weighted Average Diluted Shares | 103↓1.5% | 105↓0.4% | 105↑0.4% | 105↑0.3% | 105 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.